Академический Документы
Профессиональный Документы
Культура Документы
Faculty of Letters
Department of Modern Languages
For Non-Literary Faculties
ENGLISH
FOR PHARMACY STUDENTS
Sources:
Michaela Bücheler et al., English for the Pharmaceutical Industry, Express series, Oxford University Press, Oxford, 2010.
Michael Vince, Paul Emmerson, First Certificate Language Practice with key, Macmillan, Oxford, 2003.
D. G. Mackean, Dave Hayward, Biology for Cambridge IGCSE 3rd Edition, Hodder Education, London, 2014.
Contents
Unit 1
Kick-off p.3
Paraphrasing and summarizing p.11
Grammar: Countable and uncountable nouns p.13
Unit 2
Substance discovery and product development p.18
Grammar: Articles p.28
U nit 3
Quality assurance and auditing in the pharmacy p.32
Grammar: making comparisons_______p.44
Unit 4
Ready for testing in live organisms______p.48
Grammar: Phrasal verbs 1_______p.60
Unit 5
Drug safety and regulatory affairs______p.64
Grammar: Verbs followed by –ing or infinitive_____p.76
Unit 6
Production and packaging_______p.78
Grammar: Verb/adjective + prepositions_____p.90
Unit 7
Test yourself_______p.92
Useful phrases______p.98
Grammar consolidation______p.101
Paraphrasing and summarising
Writing information in your own words is a highly acceptable way to include the ideas of other
people in your writing. There are two ways you can do this: paraphrasing and summarising. It is
very important, however, to paraphrase and summarise correctly because there is a fine balance
between acceptable and unacceptable paraphrasing and summarising (plagiarism). You need to
learn the rules so you are able:
1. To paraphrase information NOTE: APA referencing
2. To summarise information style is used in used in this
fact sheet.
1. To paraphrase information
To paraphrase is to rewrite something using different words without changing the original
meaning. This is what is usually meant by the phrase ‘in your own words’. The paraphrase should
be clearer and more easily understood than the original and is often about the same length.
Paraphrases are a good alternative to using direct quotations.
In your writing, you may make a paraphrase of:
● short sections of text (e.g. phrases, sentences)
● longer sections of text (e.g. a paragraph)
● information that explains tables or figures.
Traditionally, in oral and written discourses, the If the gender of a person was not known or was
masculine pronoun 'he' was used as a pronoun to unimportant to the meaning of oral or written texts, it
refer to a person whose gender was unknown or was customary to use the masculine form of 'he'
irrelevant to the context. Recently, this usage has when a pronoun was required; however, there has
come under criticism for supporting gender-based been growing concern about this practice in modern
stereotypes and is increasingly considered usage because it appears to privilege stereotypes
inappropriate (Smith, 2010, p. 24). based on gender (Smith, 2010, p. 24).
11
2. To summarise information
Many assignments are accompanied by a compulsory and/or suggested reading list. No doubt you
have often wondered how your 2 000 or so word assignment could possibly incorporate all those
resources that are meant to inform your writing. Summaries of material may be used to give an
overview of the work of one or more authors, so they are much shorter than the original text.
Because they are very brief outlines of arguments made, they are very useful when you want to
indicate the support given for and/or against some position you are taking in your argument.
In your writing you may make a summary from:
● one or more paragraphs
● an entire article, chapter or complete work
● a combination of readings with similar ideas.
“For most people, writing is an extremely difficult Inexperienced and even skilled writers can feel a
task if they are trying to grapple in their language great deal of anguish when faced with writing tasks;
with new ideas and new ways of looking at them. however, this response can be managed by
Sitting down to write can be an agonising recognising and coping with personal avoidance
experience, which doesn't necessarily get easier strategies (Taylor, 1989, p. 3).
with the passage of time and the accumulation of
experience. For this reason you need to reflect
upon and analyse your own reactions to the task of
writing. That is to say, the task will become more
manageable if you learn how to cope with your own
particular ways avoiding putting off the moment
when you must put pen to paper” (Taylor 1989, p.
3).
12
FIRST C E R T I F I C A T E L A N G U A G E P R A C T I C E
120
13
G R A M MR
A 2 1 COUNTABLE A N D UNCOUNTABLE NOUNS
121
14
FIRST C E R T I F I C A T E L A N G U A G E P R A C T I C E
7 Complete the second sentence so that it has a similar meaning to the first
sentence, using the w o r d given. Do not change the w o r d given. You must use
between t w o and five words, including the w o r d given.
122
15
G R A M MR
A 2 1 COUNTABLE AN D UNCOUNTABLE NOUNS
123
16
FIRST C E R T I F I C A T E L A N G U A G E P R A C T I C E
Food habits
Breakfast is one of those (1) B.. that varies from person to person,
and country to country. For some (2) it means a (3)
of toast and some coffee. In various places I've also been offered
(4) or fruit. (5) executives might eat breakfast at the
(6) , while for many schoolchildren breakfast is a
(7) of milk at home, and then a long wait (8) the
first break of the morning, when they eat (9) or
(10) chocolate bar. Some families sit down and eat together
(11) the morning, and listen to (12) news on the
radio or (13) early morning television. For other people, the early
morning is a rush (14) work or school, and there just simply isn't
(15)
124
17
L7
Readthe explanationc and put the followlngwords or expressionsinto the correct column.
Research Development
18
l I
CaduceusPharmaceuticals
Ltd-
Date: Tuesday
To: Pharmaceutical
department- Chemistsand Pharmacologists
From: John Keyes,VicePresidentR6cD
Subiect: Breakthroughin searchfor NCE for Mensapatchrudevelopment
JK
<* ME NS A MI NT T M
Mensamin{Mis a new dosagef.orm
o{ Mensad,entrM(obtainable
with physician'sprescriptiononly).
It usesthe newly synthesized
activesubsrancemensagitatum(Latin
origin: the mind moves/
animates).
The formulation for aduh patients
is in lozengeform (or as
MensadentMin chewinggum form
for young patien6), and the
indication is to stimulatebrain
activity and thinking power.
Known sideeffectsoften include
lossof sleepif takenin the late
afternoonor evening.OccasionallS
irr.rrjr. in blood pressure
may occur.Rareinstancesof heart "r,
palpitationsand headaches
havealsobeenreported.It is ,ro,
porribl. ,o orr.rdor.
mensagitatumis non-addictive. ".rd
.:*:.-+=-.:*=;.%s.+%:'l1@r
i;:" 2
iT
An R& D meetingtakes place,in which fohn answersqu€stionsabout a new chemical
5 substance.Readhis answersbelowand write your own versionof the questions.Then listen to
the meetingand checkyour answers.l{ote: not everyquestion is askedduring the meeting.
It is already
available
in lozenge gumform,butwe hopeto develop
andchewing a time-release
oatchin the nearfuture.
Asyouknow,whensubstances
aretakenwithatcohot or antibiotics,
theirchemicalform
could
changeandevencauseharmfulsideeffects.
I'l[keepyouinformed.
ASKIl{GABOUTDRUGDISCOVERY
A1{DDEVELOP'IiEl{T
Dosage Development
Whatkindof formulationcouldwe devetop? Whatis thetoxicityof this NCE?
Whataboutusingotherforms? W hataboutthe bi oavai tabi lof
i tythi sN C E ?
or dropspossible?
Aretablets,capsules, Whencanwe startthe firstin-manstudy?
Whataboutthe dosagefor theseforms? Dowe havethe technology to makepatches?
20
20 | UNIT2 Substance andproductdevelopment
discovery
chemisto dosage
fo-rm. formulation. in-manstudy r prescription
. toxicology
r A specialist
or expertin thescientific
fietdof chemistry
is calleda . Inthe UK,
in the US.
oharmacist
theyoftenhaveproblems
because pills.
swallowing
of poisons,
3 Thescience including
theirsource,
chemicaI
composition,
action,tests,andeventheir
antidotes,
is whatwe call
4 lf a drugor medicine
is notavailable
'over-the-counter',
it normally
meansthata
froma physician
is neededto obtainit froma pharmacy.
andpharmacologists
5 Chemists arealsointerested
in howthe medicine
is administered,
so they
oftenaskaboutits
beings.
Wecallthisan . lt is alsocalleda phaser, stager study,or ctinical
triat.
Minutes of Tuesday'sbrainstormingmeeting
participants.He also
The Vicepresrdentof R&D beganthe meetingon time and welcomedall the
wasout of town and wasnot ableto attend'
mentionedthat Derekfrom Pharmacokinetics
A I Finalty,Brian askedif the new dosageform could be madewith current technology'
e I Next, therewassomediscussionabout the time frame necessary for in-man studies'
AUOtO
g\ 5 fanet, a chemist,and Brian,a pharmacologist,meet to talk about the brainstormingmeeting.
w listen and decideif the statementsa]e tsue(r'\or false (I).
6
4 [ Cream,
ointment,
andsuppository for thisproduct.
formswouldalsobe possible
S f] to maketabletsand pills.
fhe companyalreadyhasthe technology
Answer
t yet, know on We we're it don't but working
j
Answer about give the four can We weeksyou answerin
Answer
4 six year and a half We from need to monthswill a
Answer
5 to stitl tests We runningfind are out
22
productdevelopment
22 | UNIT2 Substancediscoveryand
7 natci the words from the box with the pictures,and fitl in the gaps in the fotlowing text with the
correct dosageform.
7 the correct
Calculating for somepatientsisn'talwayseasy.
2 Childrenandolderpeopleoftenhavetroubleswallowing
large
4 Somemedications in liquidform,suchas
areavailable or
23
UNIT2 Substance andproductdevelopment A
discovery
3. Averagepatient age(d)
4. Which of the followin g oral dosageforms are the p atients currently losing?
inhaled dosageforms
aerosol(nr) inhaler other(s)
topical dosage forms
cream (n) ointment (o) liniment lotion
gel other(s)
6. What kinds of side effectsdid the patients have with their current medication?
The following side effectswere experienced:
..'
"#*F+s 'ru*"us--.,','.,',@*r!s:-::, . :,+.*-ss::=+.#' "'_ " -
24
24 i UNIT2 andproductdevelopment
discovery
Substance
r Howmanypatientsweresurveyed
in a[[?
2 Weremoremateor femalepatients
interviewed?
by the patientssurveyed?
3 Whatkindof dosageformis mostpreferred
did mostpatients
5 Whatchronichealthconditions have?
2 , . drops b An smooth,thicksubstance
to rubon theskinfor healing.
8 I ; solution h A solidmedicine
whichmeltsslowlyin the rectumor vagina.
25
U N I T 2 S u b s t a n c e d i s c o v e r yparnodd u c t d e v e l o p m e n2t 5
ASK|l{GFORAt{DGlVt!16OHmOTS
to cureheartdisease.(Askfor opinion)
1 A newdrughasrecentlybeendeveloped
3 Thein-manstudiesforthisdrugwilltakemorethansixmonths.(Giveopinion)
4 Additional (Giveopinion)
shouldbe donein othercountries.
clinicaltrials
5 Thisnewformulation (Givestrongopinion)
will be successfut.
nasalspray.(Givestrongopinion)
6 A thirddosageformshouldbe devetoped:
7 Youdon'thaveenoughinformation (Avoidopinion)
to makea statement.
you haveyet.(Avoidopinion)
8 Youdon'twantto sharethe information
26
26 | UNIT2 Substance andproductdevelopment
discovery
72
@
e Whatarethe advantages of providingdrugsand medications
by prescription,
BTC,andOTC?
. Howaredrugsandmedications madeavailable in yourcountry?
. Whichmethod(s) do you prefer?
. Shouldpatientshavethe rightto obtaindrugsandmedication onlinefromothercountries?
27
GRAMMAR 22 ARTICLES
127
28
FIRST C E R T I F I C A T E L A N G U A G E P R A C T I C E
4 Complete each sentence (a-i) w i t h one of the endings from 1-9. More than one
answer may be possible.
128
29
GRAMMAR 22 ARTICLES
129
30
FIRST C E R T I F I C A T E L A N G U A G E P R A C T I C E
6 Complete the second sentence so that it has a similar meaning to the first
sentence, using the w o r d given. Do not change the w o r d given. You must use
between t w o and five words, including the w o r d given.
130
31
Quality assuranceand auditing
for'good practice''
GxP is an abbreviation
The 'x' is used to indicate the manY
differentareasof 'goodpractice'which
arerequiredby internationalregulatory
authorities'
32
28 | UNIT3 Qualityassurance
andauditing
Password:
In the pharmaceutical
industry,differentqualltyassuranceprocessesare requiredfor
eachareaof good practice
(GxP).
It is easiestto understandhowgoodpracticeworksin the areaof manufacturing. The
qualityassuranceprocessin goodmanufacturing practice(GMP)includesproductquallty
control,sampling, andtesting.Qualitycontrolensuresthat the productqualityremains
high.Thereasonfor interimtesting,or productsampling,is to checkthe qualityof
pharmaceutical products.Thisis importantto makesurethat the productis sultablefor
its intendeduse and for sale.Endpointtesting is carriedout at the end of every
manufacturing process.This is to ensurethat all procedureshavebeenperformedin
compliance withindustryandcompany standards.
Documentation is importantand necessaryqt everystep of the processes,activities,and
operationsinvolvedin drugmanufactuflng. lf the documentation
is not in order,or if the
requiredspecificationsare not met,then the productis consideredcontaminated.Proper
documentation not onlyenablestraceablllty,but also allowsa completeproductrecall
fromthe market,if necessary.
Inspectionand validationare requiredto provethat the manufacturingand testing
equipmentis functional.All operationalmethodsand procedures must also be inspected
for accuracy.
Mostcompaniesdo this voluntarily throughinternalaudit processes.
However,beyondthe fieldof manufacturing, goodpracticemust be adheredto in all
processesin a pharmaceutical
company.No processcan be consideredisolatedfromthe
others.Forexample,laboratoryand manufacturing processescannotbe regarded
separately.
A holistlcapproachlooksat all theseenvironmentsto makesurethat the
entireprocessmeetshighindustrystandards.
Standardoperatingprocedures (SOPs)are writtenand usedby companiesto makei{
easierfor them to followGxPTheseare a set of writteninstructionsto maintain
performance and results.Theyare alsothe basisof everygoodqualityassuranceand
qualitycontrolsystem.
33
UNIT3 Qualityassurance
andauditing 29
z Whichaspectof drugmanufacturing
enables
traceability?
a qualityassurance
b qualitycontrol
c holisticapproach
d documentation
2 Gompletethe following sentenceswith the correctword or expressionin bold from the text in
exercisel
r Thedocumentation
required processes
for all research anddevelopment
stepsensures
the
of a drug.
zA considers
[aboratory processes
andmanufacturing andenvironments
andnotindividually.
together
4 Quality interimandproductsampling
invotves procedures,
whicharecarried
outto checkproductquatity.
if seriousadversereactions
occur.
processes
7 Manufacturing andprocedures
mustgo throughperiodic to
guarantee
thattheyarestillofan acceptable
standard.
products
areno longerpureandacceptable
for saleor publicuseand,
34
30l UNIT3 Qualityassurance
andauditing
- InterofficeMemorandum-
Date: Monday
J. Mason
Whatkindof internalaudithasbeenscheduled?
4 Whenwilltheaudittakeplace?
5 Whatdocumentation
is necessarV
for theaudit?
35
UNlT3 andauditing 31
Qualityassurance
CAPA
Action/Preventive
Corrective Action(CAPA) is a part of the overal[QualityManagement System(QMS)
requiredfor GMP.lt focuseson the systematic investigation of non-conformance events(errorsor
deviations),to preventtheiroccurrence(forpreventive (forcorrective
action)or recurrence action).
usEFuLPHBASiS-
- il{foRmmG
This...is to advise...that ... The...is as follows:...
The...wittbe reviewed ... Pleasemakesurethat ...
Ourgoalis to ... Pleasesendus...
...department is scheduled for... Pleasetonfirm...
4 Match the tasks on the left with the phraseson the right.
3[ Yousaythe planned
schedule. c Ourgoalis to ...
4n Youaskfor verification
of some procedures
d Thelaboratory will be
information. reviewed...
6fl Yousaywhichdepartment
in the f Please
makesurethat...
companyis involved.
u
7n
::' " "'''
Yousaywhatareaswiltbe audited.
ff.:1,ffi1'.'J,'Ji,l
8I Yousaywhatshouldbe done. Thetimetableis as follows...
36
32 | UNlT3 Quatityassurance
andauditing
(your company)
- Interoffice Memorandum -
Date:
To:
From:
Subject:
Cc:
Attachment:
will carry out this internal audit from to _, using the latest company-
(dat€) (date)
The completed checklist and original audit results I with you and the Director
correct any quality system defects and to assurecompliance with industry standards, especially for
laboratory procedures.
37
UNIT3 Qualityassurance
andaudrting 3
H6
Itt
Listento a laboratorystalt meetlngin whichpreparationsfor an intemal audit of laboratory
8 safetyprocedurcs arediscuss€d. Arethe statementsVue(r') or false(,x)?
r I fnis is a plannedaudit.
5 [ Thejuniorlabtechnicians
willbe cleaning
the
laboratoriesandchecking
the workstation
equipment lists.
1 Advance
noticeof this meetingwasvery
2 procedures
makesurethatthe healthandwell-being
of laboratory
workersareguaranteed.
3 Auditorsgenerally
watchor safetyprocedures
in the lab.
workersareaskedcertainquestionsaboutsafetyprocedures,
4 Toensurethat laboratory auditors
usea
so theycantakecorrective
action.
operatingprocedures
6 Standard (SOPs)
are on a regularbasis,often
afteran audithasbeencarriedout.
oftenreadjournalsandgo to international
7 Scientists conferences,
because
theyneedto stay
in theirscientific
fields.
8 Anyobservation
or notedby the auditorsis categorized
as either
maior,minor,or critical.
38
34 I UNIT3 Qualityassurance
andauditing
8 Whatkindsof questionsaboutlaboratorysafetysystemsandprocedures
might beaskeddurlng
|
' an internalaudlt procedure?
Writedownexamplesfromyour owncompany.
lii
YY'
9 Listento a conversationbetweenan asditorandtwo tabtechniciansduringan audit of safety
i proceduresin a laboratory, and answer the questions.
4 Namesomeitemsof protective
clothingthat mustbe wornin the laboratory.
ASK|r{GQUESTTOI{S
DURilGA1{AUDTT
Talkingtostaff
Whatis yourname?
Whatis youriob?
Whatis yoursupervisor's
name?
job?
Whatis yoursupervisor's
39
U N I T 3 Q u a l i t ya s s u r a n caen oa L c : - g 35
1l Readpart of the internal audit report doneon the three laboratoriesat EernerPharmaceuticals.
Thereare ftve non-complianceareas which were observedby auditors facobs and Webkr.
Non-compliance
areas Auditors'observations
r ,-, improper
clothing/safety
equipment d foundin normalwastebins
chemicals
z i - improper
hygiene
afterhandling
animals b labmicemovedoutdoorsin opencages
4 i , improper
transportation
of labanimals o no recording times
of experiment
S i-l improper
disposal
of toxicwaste hand-washing forgotten
or sanitizing
40
36 I UNIT3 Qualityassurance
andauditing
SUGGESTIl{G
CORRECTlVE
ACTIOl{
Neutral Strong
I suggestyou put 'Notoxicwaste'onthe bin. Theonlysolutionis to rethinkthe process.
My suggestion is thatwe redothe equipmentlist. I stronglysuggestthatwe try to preventit in future.
My.recommendation is to talk to the lab workers. I'mconvinced we mustrepeatthe lasttests.
It mightbe possibleto relocatethe equipment. It is absolutely to learnthe safetyrules.
essential
t2 Write five suggestions for corrective action to solve the safety problems in the Berner
Pharmaceuticalslabs (see exercisefl). Usethe Useful Phrasesabove.
tj on laboratoryprocedures.
ReadercerptsfromBernerPharmaceuticds'SOP Thenmatchthemto
warningsignsa-e.
@
Always use
cages to
lab animals!
z i) Goodsanitaryhygienemustbe practised
by all labstaff.
3T Protective
clothingmustbe wornin the labsat alltimes.
4n Labanimalsmustbe transported
in coveredcages.
5n Eyeprotection
mustbe wornas signposted.
41
UNlT3 andauditing 37
assurance
Quality
soPs- PRocEssEs,
Dtscusslt{G PRocEDuREs,
DocutEl{TATtolt,
TtmlilG
Requestinginformation
Pleasedescribe for the ...process.
the procedure
Wouldyou pleaseclarifyhowyou ...?
Couldyouexplainthe procedurefor the documentation
of ...?
Askingquestions
Whatarethe guidelines
for...?
Howoftendo you haveto ...?
Whatspecialproceduresdo youfollowfor ...?
Howwould you ensuregood hygienein the laboratory?
FormulatingSOPguidelines
Properprotective
clothingandsafetyequipment mustbe wornat all times.
Propersafetyproceduresmustbe carriedouf by laboratorystaff.
Toxicor hazardousmaterialsmustbe disposedof properly.
mustor shouldbe +verb.
Note:SOPsoftenusethe followingstructure:
r Performa[]workwithvirus-infected
animalsin the bio-safety
cabinet.
z Usedisinfectant
on equipmentfollowinganyexperiments
with [aboratory
animals.
in the laboratory
3 Wipeup allchemicalspitls immediately.
all laboratorv
6 Document workin accordance
with GLP.
42
38 i UNIT3 Qualityassurance
andauditing
Drugcontamination:lessonsto be tearned?
A fewyearsago,a wett-known European pharmaceutical
company wasforcedto recatlone
of its drugsdueto claimsof productcontamination. Therecalltook ptacefollowingreports
frompatientsthat theirmedication hada strangeodour.Severalpatientsfroma numberof
differentcountriesmadethe comptaintwithin a shortperiodof time.A few patients
experienced nauseaimmediately aftertakingthe medication.
Unfortunatety, the drug
manufacturer wasunab[eto sayjusthowmanypatientsweretakingthis drugat the time.
However, it estimatedthe gtobalfigureat over40,000people.
Immediate investigations
showed that samptesof the tabtetscontained
abnormally
highlevetsof a harmfulgenotoxicsubstance.Thecontamination wastracedbackto its
manufacturing ptant.According
to reports,
it seems that an unanticipated
reaction
between
the drug'sactiveingredient
andthe chemicats usedas partof the cteaning
processes
at the
sitewasthe causeof the contamination.
Thecompany ctaimsthat a cteaningerrorwasthe reason for the entireincident.Thisctearty
undertines the dangerof underestimating the igrportanceof the cteaning process in
pharmaceutical manufacturing.Vatidatidil
of cteaning processes is essentiaI
in this industry,
because chemical or bacterialcontamination of drugproducts canpotentiaU.y Leadto severe
pubticheatthrisks.Regulatory bodies,suchasthe USFoodandDrugAdministration (FDA)
andthe European Medicines Agency (EMEA), require
validation of cteaningprocesses. In
fact,if thereis evidence that a company is tryingto savemoneyby reducing theircleaning
activities,theseagencies takeaction.
In the abovecase,no otherproducts manufactured by the pharmaceutical
companywere
affectedby the mistakeandthe contamination errorwasquicktyrectified.However,
the
itl patientswithoutpropermedicine.
recallleft seriousty TheWorLdHeatth0rganization
recommended that patientstry to find a suitabteatternative.
@[
. Whatroledid pharmaceuticaI
manufacturing processesplayin thisincident?
. Howcouldthecompany haveavoidedthisrecal[?
Consider the roleof qualityassurance,
quality
contro[,
audits,andinspgctions.
r Whateffectdo productrecal]s
haveon a pharmaceuticalcompany?
o Hasyourcompany everbeeninvolvedin a productrecall?
43
GRAMMAR 24 MAKING COMPARISONS
141
44
FIRST CERTIFICATE LANGUAGE PRACTICE
4 Put one suitable w o r d in each space, beginning with the letter given.
142
45
GRAMMAR 24 MAKING COMPARISONS
143
46
FIRST C E R T I F I C A T E L A N G U A G E P R A C T I C E
6 Complete the second sentence so that it has a similar meaning to the first
sentence, using the w o r d given. Do not change the w o r d given. You must use
between t w o and five words, including the w o r d given.
144
47
:I,
Agree Disagree
r AnopendayallowspharmaceuticaIcompaniesto be more
transparent policies.
abouttheiranimaItesting it ll
z Manypeopledon'trealize thatanimaltrials
arerequired
by law,
beforetestingin humanscantakeplace.
3 Testanimalsoftenhavebetterconditions
thanfarmanimals.
48
40 I UNIT4 Readyfor testingin liveorganisms
Inthe preclinical
stageof drugdevelopment,
an investigational
drugmustbetested
extensivelv
in the laboratorv.
Thisisto ensureit wiltbe safeto 1
Chemistry, andControls(CMC)/Pharmaceutics:
Manufacturing Theresultsof preclinical
testingareusedby expertsin pharmaceutical
methodstodeterminehowto
best r thedrugfor its intended
clinical
use.Forexample,
a drug
thatis intended
to acton thesinuses
maybe formulated
as a time-release
capsule,
or asa
nasaIspray.Regulatory
agencies
requiretestingthat documents -
the characteristics
chemical
composition, a, guality,andpotency- of the
drug's 5 ingredient,
andof theformulated
drug.
Pharmacology/Toxicology:
Pharmacology
is the studyof drugsandthe body'sreactionto
is the studyof thepotentialrisksto the body.
drugs.Toxicotogy
49
UNIT4 Readyfor testingin liveorganisms141
b Whatneedsto be documented
in laboratory
tests?
betweenpharmacologicaI
d Whatis the difference andtoxicologicalstudies?
b demand e possible
c makesure f goon
50
42 | UNIT4 Readyfor testingin liveorganisms
5 iliki is informing a new trainee about what she has learnedregardinga certain investigational
drug at Yine Pharmaceuticals. Completethe excerptusing the correctform of the words in
erercise 4.
to commencewith the clinical testing in humans, which is also done at our company. But before
4:
pharmaceuticalingredient into a suitable administration form. We have to
each step ofevery test very thoroughly before the regulatory agencies give their approval to
proceedto the next stage.The 5 must show that the
"'n"'"":':.:,ru sF*.
::Tj::::_:::=:*-$. e,i,#!*.#ds *Fs*_=:=s:-+=#* sEdF
AUDIO
An experiment carriedout/conducted/done/performed.
A triaUstudy
ts/was
A drug absorbed/administered/formulated/manufactured/
prescribed/taken.
Thedata provided/transmitted.
a re /w e r€
A num be ro fe x p e ri m e n t, conducted/done/performed.
SeveraItests
z Lastyear,resultsof preclinical
testing to comeup withthe best
formulationof the intendeddrug.
51
U N I T 4 R e a d y f o r t e s t i n gliinv e o r g a n i s m s/ 3 : 1
3 Extensive must
documentation regulatory
to the appropriate authorities.
4 A drugintended
to acton theskincan asa cream.
risksto humans
5 Potential in toxicitvstudies.
6 Therequirements
of drugbioavailability howit will
determine to humans.
r told Lindathatthedogswerevomiting.
Someone n
z Somedogswerenot affectednegatively
by the drugsubstance. l_]
5 Thestudyprotocol
will haveto be changed. I
6 Rogerwill contactthe studydirectorby the endofthe day. L_'.
THE!ilSAilDOUTS TR|AIS s
OFCLrt{|CAL
assistschemists
A chemistrylab technician andchemical engineers andrelatedproducts,
usingchemicals
whereasa biolorylab technician
workswith livingorganisms.
In preclinical
triats,at leasttwo differentanimalmodelsarenecessary:
r Testingis donein rodents(e.9.mice,rats,but alsorabbits,and/orguineapigs).
z Testingis thencarriedout in animatswhichhavesystemsmoresimilarto humans, e.g.dogs,mini-pigs,
and/ormonkeys.
Theactiveingredient
canbe testedin humansonlyafterthesetestshavebeensuccessfully and
completed
hasbeengiven.
authorization
52
44 | UNIT4 Readyfor testingin liveorganisms
Couldsomebody fitl me in on ...? | suggestmaking... I'll let you knowwhatwe comeup with.
I'dtiketo knowwhathashappened. I suggestwe take... I'mnot sureI agreewithyouon that.
Doesthat mean...? Wecouldconsider trying...
I haveheard.... ls that correct? So,we'dbettertest ...
8 Unscramblethe words. tlake questionsor sentencesto ask for and ctarify information,
makesuggestions,and respondto suggestions.Notethat eachtime there is one word you
do not need.
4 couldWe considertestinggroupwithbutanotheranimalsof
9 Chooseone of the situatlons below,or think of one at your company.Thenfollow the flowchart
to discussthis subiectwith a partner. Usethe Useful Phrasesabove.
- Theamendment
Situations: to a studyprotocol
hasnot beensigned.
- Thebodyweightof the animalshasnot beenfitledout for Day3.
- Atlthe micein the studyhavestartedscratching
themselves.
PartnerA PartnerB
53
UNlT4 Readyfor testingin tiveorganisms /|.5
Natar
'[he gewral hzalth of thz drys was
r I fhe anima]s
thatshowedclinicalsymptomsa werecheckedtwicea day.
z I in the high-dosegroup
Ctinica]symptoms to be watchedmore
b wereseparated
intensively.
I fne general
healthandbehaviourofthe werefoundin the low-andmid-dosegroups.
dogs
[ ruomajorclinical
symptoms d werediscovered
soonafteradministration.
ultftf,G toE^s
54
46 I UNIT4 Readyfor testingin liveorganisms
t2 Usethe ryordor phrasein bracketsto link the two ideas.tn somecasesyou wilt still havetwo
sentences.
r Therewereno clinical
findings group.Thehigh-dose-group
in the mid-dose animals
showed
c.tinical
symptoms.(while)
z Thepulseratewasincreased. washigh.(notonly...butalso)
Thebloodpressure
3 Therewereno clinical
findings
in theoraladministration Therewereclinicalfindings
studies. in
studies.(however)
the intravenous-dose
(furthermore)
5 Thedrugwaswelltoleratedby rats.lt did not haveanyeffecton bloodpressure.
t3 After getting a closeinsight into preclinicaltesting, ttiki woutd tike to know what comesnext,
and asks a colleaguefor help. She gets tbe fotlowing emai[.
From: jill.sanders@VinePharmaceuticals.com
To: miki.takashi@VinePharmaceuticals.com
Re: Phasesin ClinicalTestinq
Dear Miki
At lunch yesterdayyou asked me to send you some generalinformationon clinicaltrials.Hereis a rough
summarythat might be useful.
Phase I Trials: These are studies which are performed to evaluatethe safety of drugs in healthy people,
and to determinethe pharmacologicalpropertiesof drugs.They are done to find out how the drug reactsin
the body. Toxicity,metabolism,absorption, and excretion are observed and documented.
Phase ll Trials: These are controlled studies conducted to evaluatethe efiectivenessof the drug in a
particularindicationand to determinepossibleside efiectsand risks.Thesestudiesare performedon
volunteersand a numberof patientswith the targetdiseaseor disorder.In this phase,testingdetermines
the safetyand efficacyof the drug in treatingthe conditionand establishesthe minimumand maximum
effective dose.
Phase lll Trials:After gainingevidencethat the drug is effective,these controlledand uncontrolledtrials are
carriedout to obtain additionalinformationto evaluatethe overallbenefit-riskrelationshipof the drug. In
this phase,a largegroup of patientsis studiedand closelymonitoredby physiciansfor efficacyand any
adverse events after long-term exposure to the drug.
Phase lV Trials: These are post-marketing studies after getting approval for general sale. They are carried
out in order to gather further information about the drug's safety,efficacy,and optimal use.
Best wishes
Jitl
55
UNIT4 Readyfor testingin liveorganisms 47
Whichphasedoeseachdescriptionbelongsto?
r Phase is performed
afterthereis preliminary
evidence
that the drugis effective.
4 In phase , furtherinformation
regarding
the idealuseof thedrugis col[ected.
It{slDEcl|l{tcAt TRTALS
An adverseeventis anyabnormalmedicaloccurrence in
a patientor clinicaltrialsubjectaftera medicinal
product
hasbeenadministered. lt doesnot necessarily
havea
causalrelationshio withthe medicinal oroduct.
Adversereactionrefersto a[[abnormaland unintended
responses to an investigational product
medicinal
relatedto anydoseadministered.
r wantsto lookat
Theinspector
manual.
a an instruction
datagathered
b the detailed duringtheclinical
trial.
z Theinspector
a did notacceptthe documentationaboutthechangein temperature.
b consideredthe incorrect
changeto the documentation
to be minor.
56
/f8 | UNIT4 Readyfor testingin liveorganisms
z What'syourexplanation
for ...?
3 | assureyou ...
5 DoI understand
correctly?
Youwantmeto ...
6 Thisis howyoustop...
57
UNlTif Readyfortestingin liveorganisms 49
Pautlttliltiams RichardThompson
Askaboutdocumentation
ofa change Saywhereto findit
Warnaboutpossibleproblems
with authorities Acceptwarning
Askfor explanation
ofthe change Double-check
request
Confirm Explain
thechange
Showsatisfaction
with explanation
Moveon to nextsubiect
18 Thefollowingwordsareoftenconfused.
Putthe correctoneinto the sentences.
lf necessary,
look backin the unit. At least one word of eachpair has beenused in this unit.
illness/disease
r Thereis a historyof lung in the family.
z Hemissedfivedavsof workbecause
of
sensitive/sensible
3 Dogsaremore to drugsthanmini-pigs.
4 ltwasa decision
to cancelthetrial.
affect/effect
5 | felt the of the newointmentrightaway.
6 Theactiveingredient
currentlybeingtestedseemsto thekidneys.
shortly/briefty
Z Theadverseeventoccurred aftertheinjection.
8 Thetrialdirector
spoke to hisstaffabout
thecurrentstatusofthetrial.
58
50 i UNIT4 Readyfor testingin liveorganisms
ExperimentalDrugs on Trial
G@[
justifiabte
ls it ethicatty ill patients
to denyterminally accessto potentially
life-saving,
experimental
drugsandmedicine?
Wouldeasieraccess to experimentaldrugshavean effecton obtaining reliabledataon thesafety
andefficacy ofthe drugs?
Whatcanauthorities do to provide
termina[[y ittpatients
withdrugsthatcouldhetpthem?
59
GRAMMAR 26 PHRASAL VERBS 1
Rewrite each sentence so that it contains the phrasal verb in brackets. You may
have to change the f o r m .
a) Sorry, but I haven't found time to fix your bike yet. (get round to)
got round to fixing your bike yet.
d) Julie must be too old to bite her nails. (grow out of)
f) I don't think I'm well enough to play football today. (feel up to)
60
FIRST C E R T I F I C A T E L A N G U A G E P R A C T I C E
2 Complete the second sentence so that it has a similar meaning to the first
sentence, using the w o r d given. Do not change the w o r d given. You must use
between t w o and five words, including the w o r d given.
154
61
G R A M M A R 26 P H R A S A L VERBS 1
155
62
FIRST CERTIFICATE L A N G U A G E P R A C T I C E
5 Choose the most suitable ending for each sentence. Note that some of the phrasal
verbs have a different meaning to the one given in the Explanations section.
Key points 1 Check any new phrasal verb in a dictionary to see how it is used.
2 Remember that many phrasal verbs have more than one meaning.
3 Phrasal verbs tend to be more common in spoken language and informal
written language.
156
63
Drug safety and regulatory affairs
DrugSafety RegulatoryAffairs
r Reporting
an adverse
drugreaction
to healthauthorities.
-
z Submitting
documentsneeded
to obtainmarketing
for a drug.
approval
3 Monitoring
andevaluating
suspected
sideeffects.
to a physician's
4 Responding report.
dossiers
5 Compiling for submission
to authorities.
forthe patient.
6 Writingthedruginformation
TheGreekword'pharmaco' (medicine)
andthe
(watchfulness)
Latinterm'vigitantia' wereput
togetherto formthe wordpharmocovigilonce.
Government pharmaceutical
agencies,
companies, andhealthcareprofessionalswork
togetherto monitorandevaluate suspected 'a a a a
64
52 | UNIT5 Drugsafetyand regulatoryaffairs
AD D IT ION ALEF F EC T S
O F T AKIN GD R U G S
q
Sideeffect - any unintendedreactioncausedbv a
{
drug or medicaltreatmenr.This term is rrsej bv I
Doctor'sreport:
On24Dec 2010, a woman of unknown age,Maria Gallois, fainted after developing a
sudden, severeskin rash and inflammation all over her body.
Ms Gallois, the well-known opera singer,lost consciousness30 minutes before she had
planned to go on stage.Shewas taken*tohospital and regainedconsciousnessan hour
later. She reported that she had not had anything to eat except some chocolate four hours
before. In addition to small, red, itching spots all over her body, she also reported a racing
heart, a headache,and insomnia after starting on MensamintrMthree weekspreviously.At
the hospital, the patient showedevidenceof hyperactivity, accompaniedby confusion and
agitation. Subsequently,MensamintrMwas discontinued,but the symptoms persisted until
a strong sedativewas administered.After 24 hours, all symptoms exceptfor a mild skin
irritation had subsidedand the patient was dischargedfrom hospital. Some symptoms are
suspectedside effectsof MensaminfM.
The patient has a history of hlryertension, mild heart palpitations, high adrenalin levels,
and often suffersfrom insomnia.
Frede.rirk/vI. WrgW
FrederickM. Wright,MD
AttendingPhysician
65
UNIT5 Drugsafetyand regulatoryaffai.s 5:l
r Whatwerethe patient'ssymptomsbefore
shewasadmittedto hospita[?
2 Howwasshetreatedby herphysician?
3 Whatwasherconditionwhenshewas
fromthe hospita[?
discharged
2 ilatch the following symptomsin bold in the doctor'sreport with their definitions.
r I hypertension a . sleeplessness
z I rash b generaldiscomfort,
badfeeling
3 [ palpitation c red,warm,andswollen
5 [ inflammation e heartracing
e I itching f highbloodpressure
1 n fromthe patient'ssister
A reportreceived a the attendingphysician
reducedthe dosage
to ro mg perday.
3 n A correlation
between
MensomintrM c headaches
andinsomnia.
a I ffrepatienthasnowcomp]etely d indicated
that shehada historvof
hypertension.
5 [ thepatient,
nter examining recovered
andis backon stage.
Correct
order:
66
54 I UNIT5 Drugsafetyand regulatoryaffairs
REPORTIl{G ADVERSE
SEVERE EVEIITS
TO HEATTH
AUTHORITIES
Patienthistory Druginformation
Thepatienthasa historyof ... ...areknown/suspected sideeffectsof thisdrug.
A reportwasreceived fromthe physician indicating tL;rrg1v735 admi ni stered
for { c* ndi ti on).
t hat . . . Eyedropswereinstilled.
Beforethe event,the patientwason the fottowing A bandage/cream/l oti on/oi ntment w asappl i ed
medication: ... (tothe skin).
a a historyof g correlation
between
b a reportwasreceived h showedevidence of
c the patient
afterexamining i suspected sideeffects
d allsymptoms hadsubsided j the patientreported
e be ruledout k vitalsigns
f wasconcomitantlytaking
67
U N lT 5 Drug safety and regutatorvaffar':
IleoWntcr
For VOLUNTARY reporting of
advercewents, product
:t problems ar
and
product use enots
erorc FU 6 6 t
Ihe FDA S.irty Iniormedon and
AdneEc Evcnt Roportng Program Page I of_
of
O.t otglrth:
! rcmar _rb
a1
,, tOO;;1 1;C-
Aaril-G uaknoutn i2
hqti&ne
! uau
-kg
, e.6 ct v.. u. unMw4 gw Mw, tw
tqwtgMad) slopp.d 6 DG! R.dcrd?
68
I
56 | UNIT5 Drugsafetyandregulatory
affairs
HEATTH
AUTHORTTIES
AilD USEFUL
TERTS
Thenamesof heatthauthorities
andothertermsusedin pharmacovigilance
areoften
shortened.Herearesometypicalexamples:
EMEAEuropean Agency(EU)
Medicines
(US)
FDA Foodand DrugAdministration
MHRAMedicines
andHealthcare
Products (UK)
RegulatoryAgency
PSUR Periodic
SafetyUpdateReport
SAE SeriousAdverseEvent
PersonResponsible
QPPV Qualified for Pharmacovigilance
I process
approvat
f clinicaltrial
I doctor's
report
I lastauditreport
I QualityAssurance
I soes
AUDIO
A llow listen to the meeting in which Karl (CEO),Fred(Headof Regulatory Affairs), and Caroline
a7t
v
(Headof Pharmacovigitance)dlscuss the SAEand its implications for the company.Are the
followlng statements true (r') or false (t)?
69
UNIT5 Drugsafetyand regulatoryaffairs 5?
5 Werethe clinicaltrials
successful?
6 Thefactsneitherprovenordisprovethis.
70
58 I UNIT5 Drug sa f et y and
r egulat or y af f air s
1 Administrative
Data
2 Common
Technical
Document
Summaries
Quatity
4 Non-clinical
StudyReports
ClinicalStudy
Reports
a biological, andpharmaceuticaI
chemical, documentation quatitycontro[,
withmanufacture, and
testingdata
of quality,
b overviews clinical,
andnon-clinical
data
c documentation trialsandpost-marketing
aboutclinicaI information
d general
information,
suchasthe marketing
authorization form,aswellas product
application
characteristics
andlabetting
pharmacology,
e studyreports, pharmacokinetics,
toxicology,
andreferences
P I L V S . P IL t
-
Hereare your pills-
and here is your PII=
71
UNIT5 Drugsafetyand regulatoryaffairs 59
Dear RA staff
ljust wanted to give you a brief update on the self-inspectionconducted last week by QA.
Most of the resultswere very positive.lt seems our documentationis of a high standard,
especiallywith respectto completenessand technicaldetails.However,in terms of
readability,we can still make some improvementsin future patient informationleaflets.We
need to rememberthat not only healthcareprofessionalsread these PlLs, but also patients.
In addition,I have noticed somethingwhich, I think, some of you can improveon. lt has to
do with drug warnings.Yes,we do need to let patientsknow of any possibleside effects.
But, no, it is not necessaryto alarmthem unnecessarily.In other words, in future when
describingpossibleside effectsfor products in the pipeline,we will need to differentiate
more clearly between frequent and rare risks. ln the case of the latter,we will need to be
less direct in order to increasepatientcompliance.
Let's talk about these two points at our departmentmeetingon Friday.I will also be asking
Wendy,our seniormedicalwriter,to coach junior staff members.
Best regards
Fred
its documentation?
z Howcouldit improve
haveon patients?
3 Whateffectcoulda changein the styleof language
72
60 | UNIT5 Drugsafetyand regutatory
affairs
PATIENT
INFORMATIONLEAFLET
MENS A M I NT *
3
Do not tokeMensomint'"if you ore ollergicto peonuts.
lf you hoveo hisloryof heorltrouble,consultyour doctorbeforetoking.
4
Toketwo lozengeso doy, morningsond eorly ofternoons.
6
Storebelow 25'C in o dry ploce.
CoduceusPhormoceuticols
'l54
Freshfield
Street
Milton Keynes
73
UNIT5 affaia Gl
Drugsafetyandregulatory
cryllrc GEi{ERAL
ADVTCE glv!]tc STnOilG
WAnilrilGS
tl Here is some lnformation from the PIL for a new drug called Pogoloxrn. Match the following
sentences halves used in the leaflet.
z [-*l
3 [-_l
4 l--l
t'----'l
)- L I
6[-_l
7 f-l
74
62 | UNIT5 Drugsafetyand regulatoryaffairs
75
FIRST C E R T I F I C A T E L A N G U A G E P R A C T I C E
2 Complete the second sentence so that it has a similar meaning to the first
sentence, using the w o r d given. Do not change the w o r d given. You must use
between t w o and five words, including the w o r d given.
168
76
G R A M M A R 28 VERBS F O L L O W E D B Y - I N G O R I N F I N I T I V E
Key p o i n t s l Check new verbs in a good dictionary as it will show how they should be used.
2 Note that some verbs can be used in different ways with changes of meaning.
169
77
GI
ri
o, Production and packaging
Whichof these signs would you erpect to flnd when you visit a pharmaceuticalcompany?
Do you knowwhat they mean?
5rE
AU0to
r Whatdid RRBproduce
originally?
4 Whencanthe visitorsasktheirquestions?
78
64 | UNITG Pro du c t ionandpac k aging
Past Specifyingparticularmoments
Whenthe componywasfounded,it onlysold Whilewatchingthe fi[m,...
one product. Duringthe tour,...
ln thepastwe produced
everything
ourselves.
l{ow talk about your company.andiob. Useas many of the Useful Phrasesaboveas possible.
z and processuncomplicated
simpleThe be productionto used
3 documented
use clothingThe didn't be specifications
to
79
UNIT6 and packagirq 35
Production
7 facemask fj 5 overshoes i,
2 haircoveringI 6 shoes t-:
protective ir
4 overalls n 8 safetygoggles ll
80
66 i UNIT6 andpackaging
Production
Grvllrc !ilSTRUCTIO]rS
lf you giveinstructions
in a verydirectway,it maysoundimpolite.Therefore,
it is importantto watchyourtoneof voice,andhowyou phraseyourinstructions.
SAIETY
VS.SECURITY
3
4
)
81
UNIT6 and packagng 67
Production
at rt rm
r1l n Bl f4l
30
3
9 Thegroupmoyeson to seethetabletproduction
unit at nnB.look at the diagrambelow.
! + sieve
flr nuiabeddryer ! s Tabletpress
[ 6 rxcesspowderremover
82
68 I UNIT6 andpackaging
Production
of the production
Readthe description process,
andnumberthe stepsaccording
to the diagram.
A I goupa spiral,
Asthetabtets theyareshaken, powder
andtheexcess isvacuumed
off.
Thepressed tabletsareput intoa drumandstoreduntitit is timeto coatthem.
B LJ In the granulator,
the ingredientsaremixedto createa wet mixture.
cE ' Thewet granulesarepressedthrougha sieveon theirwayto the fluidbeddryer.
D fl Thegranulesareair-dried.
h L__ Thedriedgranules arestampedintoa mouldto formtablets.
F T Dryingredients areweighed andtransportedto thegranulator bythe hoist.
DEscRrBrlrc (plnr z)
A PRocEss
Thepassive
canalsobeusedwhentheagentis known
or
relevant.
Forthis,by + agentis added.
3 A shakerloosensthe excesspowder.
5 A drumholdsthe pressed
tabletsuntilit is timeto coatthem.
83
U N ITG P roducti onanC :ac<as -; 6[}
f,"
tt
tt After the tour of the tablet productionarea,the visitors are given a presentationon some
18 different aspectsof the pharmaceuticalindustry. Listento part of the presentationHenry Xaylor
is giving to the self-help group on one aspectof compliance.Decidewhetherthe statementsare
true (/) or false (X).
r at theendof hispresentation.
i ] Henrywantsthevisitorsto asktheirquestions
haveto complywithGMPguidetines.
companies
z [__]eharmaceutical
3 f] Thedifferentcolourzonesonthefloorsindicatetheseparationofcertainfunctions.
equipment
5 [ I Production untilit is takenintooperation.
doesnotneedto bevalidated
G I V I l { G P R E SE I {T AT IOl{ S
Signposting Finishing
Movingon to the nextpoint,... Finally, I wouldliketo add...
As I mentioned ...
earlier, A s a.fi nalpoi nt,I w oul dti keto say...
Comingbackto ... Torecap,...
Letmecomebackto whatI saidbefore... I hopethi shasgi venyouan i deaabout...
Addingpoints
t o t h i s ,...
I naddit ion
Moreover/ Furthermore. ...
Apartfromthis,...
84
70 | UNITO Productionandpackaging
a) EnioYwg c) bniLdLvgs' ,
ni i^'z b) Cowtwte
'o owto cLatliA'
/) what ts packagwg tralnlry
F .: J
q/'lP? ""- "'s
humidity
:-A-z
I
( R,sK
)
primarypackaging
material
-,\/\--
I
Whywouldthey bea risk for the productquatlty?
85
andpackaging 7L
UNIT6 Production
/+ A(n) glasscontainer
is a multi-use witha twist-onlid.lt canhold
or anykindof fluidsor solids.lt canbe openedandclosedseveral
pharmaceuticals, timesuntil
thecontentsareusedup.Sometimes a desiccant intothecapsothatthecontents
is integrated
remaindry.
s A(n) bagcontaining
is a smalldisposable an individual
doseof the medicine.
It oftenhasa perforation
lengthwise whichcanbe torn open.
86
72 | UNIT6 andpackaging
Production
18 Whichof the verbsin the box are usedwith the following primary packagingforms?Why?
1 Synnge 4|,ar
z sachet s inhaler
3 blisterpack
CH!LDPROOF
VS.ELDERLY-ACCESSIBLE
is doneto makepackaging
A lot of research childproof,
i. e. a childcannotopenit alone.However, at the
sametime,the elderlymusthaveeasyaccessto their medication,i. e. it needsto be elderly-accessible.
19 Read the foltowing tert about childproof packaging and unscramble the letters in the brackets
to find the correct word.
' (sacnihmsem)
that arephysically
easyto open,evenfor the e 3
(dyelert)
or infirm,but that requireactionsto be'ftrought
throughin a waysmallchildrenwou]dnot
bec a (aaclbep)
of. Psychologists,
e : (gieneesrn),
anddesigners
have c 6 (bocallradeto)
andcomeup with the fotlowingstate-of-the-art
features.
5 .] peet-push
system e A tubethat canonlybe releasedby an adutt-length
fingerby pushing
an internalcatch.
Readthearticle.
@
B O YK I t t E D B Y P O T E N TPAIN PAT CH
88
FIRST C E R T I F I C A T E L A N G U A G E P R A C T I C E
89
G R A M M A R 29 VERB/ADJECTIVE + PREPOSITION
4 Complete the second sentence so that it has a similar meaning to the first
sentence, using the w o r d given. Do not change the w o r d given. You must use
between t w o and five words, including the w o r d given.
173
90
FIRST C E R T I F I C A T E L A N G U A G E P R A C T I C E
174
91
741
UNIT 7
Test yourself!
See how muchvocabulary you have learned. Use the ctues to complete the crosswordpuzzle.
Across
5 A taskperformed to fix something wrong.
5 A condition in whicha partof the body becomes red,warm,andswollen.
7 A placewherea companyhasits officesand/orfactories.
8 An unwanted medicaI occurrence duringa clinicaltrial.
7t Paperwork necessary to provideevidence or proof.
t2 A carefulstudyof a substance donebeforemedicineis developed.
74 A writtendescription of changes to a studyor trial protocol.
r8 Togiveor handin, e.g.a documentation to an authorityto obtainauthorization.
zz AnAmerican drugauthority.
27 Following rulesand regulations madeby peoplein authority.
z9 Ioput a coverovertablets.
3t A writtennotefroma doctorfor medicine.
33 Equipment usedto lift something.
34 the practice of makingsurethat goodsandservic'es fulfildefinedstandards.
35 Trialsto testa drugin humans.
36 A taskperformed to stopsomething badfromhappening.
Down
7 An examination of processes, procedures, andstandards.
2 Medicine provided by a chemistor pharmacist withouta prescription.
3 A mechanism whichreleases its contentsin definedamounts.
4 A mechanism or piece of equipment designed to performa special
function.
9 A difference from a specification,not withinthe accepted range.
10 Monitoring or evaluating suspected sideeffects.
73 A fixedworkingmethod,oftenwrittendown.
75 A substance recentlydeveloped.
16 Theabitityof a drugto treatthe illnessfor whichit wasdeveloped.
t7 An information sheetexplaining howto takea drug.
t9 Givingoff smallbubblesof gaswhenaddedto liquids.
20 Permission to sellanddistributea newdrug.
27 A persontrainedto do testson drugingredients.
23 Medicineobtainedin retailoutletswithouta prescription.
24 Features or characteristics ofa drug.
z5 A person whoagrees to participate
in a clinicaltrial.
z6 A typeof medicine, e.g.tablets,powder,ge[,spray.
z8 A substance in a drug.
3o A sma[[ animal usedas a subjectin the earlierstagesof preclinical
trials,e.g.mouseor rat.
3z A prescribed amountof a medicine or drug.
92
Testyoursetfl | 75
!1 =r
l
. : ; , i I i24i ;
.-, i .; l---r; i
. i
,*
:,.1;25 ,r=l=[r
i: ...: ; J
r
i - i .' i ; ;n i i' ' ' ' l- i i- - :
li -'l
l-
I
I
Llir
i______l
93
76 1
Partner Files
94
Files Tf
Partner
Youarea drugsafetyspecialist.
A patientcallsyou.Findout the following
information:
. fu[[name,age,address, attendingphysician
o nameof all drugstaken,periodof time,dosage
. descriptionof symptoms, periodof time
. medicalhistory,anymajordisorders.
Askthe patientto consulttheirdoctorif theyhave
notyetdoneso.
Suggestthe patientmightneeddifferent
medication.
Informthe patientthatthiswill be reportedto the
if youthinkan adverseeventhas
authorities
occurreo.
95
78 1
Partner Files
96
PartnerFiles 79
3 Contaminated laboratoryclothingmustbe
removed immediately. Explain
howdirectskin Youarea patient.
contactcanbe avoided (seeexercisery for help).
4 Specialcontainers areprovidedfor the disposalof Readthe patientinformationleaflet.
toxicwastematerials. Namesomekindsof
materialsthesecontainerscouldbe madeout of.
Sayhowthe containers canbe recognized. Possiblesideeffucts
5 Onlythe resultsof experimentsaredocumented. Common sideeffects
of CAREFREEDO
ore:
Thisdoesnot necessarilvhaveto be done . nouseo
immediately. o vomiting
r obdominolpoin (poin in your slomoch
Reportbackto the groupanyareasof non-
or intestines!.
thatwereidentified.
compliance
Whatwasagreedin orderto achievecompliance
in In rore coses,the followingmoy occur:
future? o dizziness
r ollergicreoctions(for exomple,o rosh)
r elevotedblood oressure.
Furlherinformofion
A pharmaceutical Systematictestingof Coll 0041 303889222
formofan active a drugin humansto
ingredientwhichis determineits
Youhavebeentakingthismedication for two weeks.
testedin a clinical pharmacological
Sincethenyou havebegunto feeldizzy.Yesterday
trial. effectivenessand
youactuallyfaintedandweretakento hospitat. You
safety.
investigationaldrug wereableto leaveafterfive hours.
ctlnicattriat Youhavea historyof dizziness wheneverthe
weatherchanges. At the momentthe weatheris
Theamountofa drug Recordsof a trial, stable.Youalsohavehayfeverand areallergicto
administered to an includinginformation severalpollens.Thisis the reasonyou takethis
animal,heatthy on dosages,methods, medication.Youthinkthatyourfaintingand
volunteer,or patient. results,factors,and dizzinessarea resultoftakingthisdrug.
actionstaken. Callthe pharmaceutical company anddescribe your
dosage situation.
documentatioo -
Theshortformof a A personwho
- Cor/i* sizz ofgroup (l)
signatureusingthe performstestsin a
- Qo two stertJc otrea?
first lettersof your biotogyor chemistry
name. laboratory. - Luwh with Head of productwd
- Vkit pack4givEarea?
lnitials lab technician
.-="=-
.:".:..====: =...- . J
Addanyotherquestions
you mayhave.
Tryto find compromises.
97
s4 l
Useful phrases
98
UsefutohrasesI 95
Thedata provided/transm
itted.
are/were
A numberof experiments conducted/done/performed.
Several
tests
Talkingtostaff
Dosage Whatisyourname?
Whatkindof formutationcouldwedevelop? Whatisyourjob?
Whataboutusingotherforms? Whatisyoursupervisor's
name?
or dropspossibte?
Aretablets,capsules, Whatisyoursupervisor's
lob?
Whataboutthe dosagefor theseforms? Askingaboutprocessesand procedures
Development Howhaveyoubeentrained to perform
thisprocedure?
Whatis thetoxicityof thisNCE? Howmuchtimedoesit taketo complete thispartof the
Whataboutthebioavailability of this NcE? process?
Whencanwestartthefirstin-manstudy? Whatspecial procedures
mustbefollowed in a
Dowe havethetechnology to makepatches? laboratory?
Whatspecial procedures
mustbefoltowed forthis
process?
Askingaboutpossibleactionstaken
Givinginformationat inspections Howdo youhandletoxicwastein the lab?
Herearethedocuments yourequested. Howdoyouhandle thetransportation of animals
in the
I'll getit immediately. lab?
Youcanfindthison pagethree. Whatwouldyoudo ifyou gota toxicsubstanceon your
Thechange out,initialled,
is crossed anddated. labcoat?
Letmeexplainin moredetail... Whatwouldyoudo if younoticed non-compliancewith
I cangiveyoumorespecificinformation on ... safetyprocedures
bya colleague?
Explainingandiustifyingdecisions
Letmedemonstrate...
Wehadno alternative butto ...
I assureyou...
Youcanrestassured thatwewill ...
Thatledto...
Thisway,youcan/willavoid...
99
s6 l Usefulphrases
ileutral
I suggestyouput'Notoxicwaste'onthebin. Pharmaceutical companiesusedetailsfromdoctors'
Mysuggestion is thatweredotheequipment list. in a casereport.
reportsto informtheauthorities
Myrecommendation is to tatkto thelabworkers.
Patienthistory
It mightbepossibleto relocate theequipment.
Thepatienthasa historyof...
Sttong A reportwasreceivedfromthephysician indicating
Theontysolution is to rethinktheprocess. that...
I stronglysuggest thatwetry to prevent it in future. Beforetheevent,the patientwason thefollowing
I'mconvinced we mustrepeat thelasttests. ...
medication:
It is absolutely
essential to learnthesafetyrules.
Descriptionof adverseevent
Afterexamining thepatient,thephysician
...
Aftertaking(drug),the patientexperienced
...
At thetimeof thereport,thepatient's
condition
Requestinginformation was/remained unchanged.
Please the procedure
describe forthe ...process. At thetimeof thereport,thepatientwas
Wouldyoupleaseclarifyhowyou...? recovering/hadcompletely recovered.
Coutd youexplaintheprocedure forthedocumentation Thiseventledto the patient's
death.
of ...?
Druginformatlon
Askingquestions ...areknown/suspected
sideeffectsofthis drug.
Whataretheguidelines for...? (Drug)wasadministeredfor {condition).
Howoftendo youhaveto...? Eyedropswereinstilled.
Whatspecialprocedures do youfollowfor...? wasapplied
A bandage/cream/lotion/ointment (tothe
Howwouldyouensuregoodhygienein the laboratory? skin).
FormulatingSOPguidelines Assessment of adverseevent
Properprotective clothingandsafetyequipment must (Drug)is (not)believed
to be relatedto theevent.
be wornat all times. An interactionbetween(drugx) and(drugy) was
Propersafetyprocedures mustbe caniedout by.* Susoectecl.
laboratorystaff. between(drug)and(symptom)
A correlation can/
Toxicor hazardous materialsmustbe disposedof cannotberuledout,
properly.
Note:SOPsoftenusethefollowingstructure:
mustol
shouldbe +verb It coutdhavebeendueto...
It is dueto pre-existing
conditions.
Theevidence is conclusive/inconclusive.
lf yougiveinstructions A reaction to theproduct cannotberuledout.
in a verydirectway,it may
soundimpolite. Therefore, to watchyour
it is important
toneof voice,andhowyouphraseyourinstructions.
Howdidtheclinical trialsgo?
Notethatwhenyoutellpeopleto do something
Whatis the statusof approval?
mandatory if youadda simple'please', your
it makes
Howfar is it fromapproval?
instructions
soundmuchnicer.
Couldit ieopardizeotherproducts?
e.g.Pleoserememberthat theovershoesareonly Whatdoesit meanfor the productsin the pipetine?
allowedto touchthe whiteorea.
Notethat'mustn't'means thatyouarenotallowed
to
do something. Mensomintrt moycausedizziness.
Mensomintrtconinteractwithothermedicines.
e.g.Theremustn'tbe morethanthreepeoplein the
gowningroomat a time. Likeall drugs,thismedicinecancausesideeffects.
UseMensomintrtwith cautionwhiledrivingor
Politeinstructions undertaking activities.
dangerous
Couldyouplease... ? It is possiblethatyoumayreceivethismedicine,
or an
Wouldyouplease... ? alternativemaybe used.
Please makesurethat...
Pleaseremember/Don't forget...
Please keeoin mind...
l/Weneedyouto... Donot use/takeMensamintru if ...
Stopuseandaska doctorif ...
Keepout of reachof children.
Tellyourdoctorimmediately/right awayif ...
Youmustnot drivewhiletakingthisdrug.
YoushouldnottakeMensaminf rn if you have
a historyof ...
100
Unit 7
Put one suitable w o r d in each space.
Holiday problems
Somehow I always have problems when I go away on holiday. (1) every.
year my travel agent promises me that my holiday will be (2) best
I have ever had, but none of these promises has ever (3) true. This
year I got food poisoning (4) day I arrived. It must have been the
fish I ate at the hotel (5) evening. In (6) morning I
felt terrible, and I was seen by two doctors. I tried to explain my problem to
them, but (7) of them spoke English, (8) didn't
help. It took me (9) of the first week to recover, and I spent three
or four days sitting next to (10) hotel swimming pool reading
newspapers. By the time I felt better, (11) weather had changed,
but I was determined to go sight-seeing, and do (12) swimming.
Unfortunately (13) of the museums were open, as there was
(14) strike. I would have enjoyed myself (15) if I
had stayed at home.
2 Complete the second sentence so that it has a similar meaning to the first
sentence, using the w o r d given. Do not change the w o r d given. You must use
between t w o and five words, including the w o r d given.
146
101
G R A M M A R 25 CONSOLIDATION 5
147
102
FIRST C E R T I F I C A T E L A N G U A G E P R A C T I C E
4 Rewrite each sentence so that it contains the w o r d given in capitals, and the
meaning stays the same. The w o r d cannot be changed in any way.
5 Complete the second sentence so that it has a similar meaning to the first
sentence, using the w o r d given. Do not change the w o r d given. You must use
between t w o and five words, including the w o r d given.
148
103